Explore more publications!

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on October 22, 2025

Internationally Acclaimed Orthopedic Surgeon Dr. William Andrew Hodge Outlines Medicare’s Future at DisasterPlasty
Excelsior University launches Florida site for immersive new learning opportunities
MPLT Healthcare CEO Liz Hale Named SIA’s Global Power 150 Women in Staffing for Third Consecutive Year
SABER College celebra la Semana de los Asistentes Médicos y mantiene abiertas las inscripciones del programa.
SABER College Highlights the Role of Medical Assistants While Continuing Enrollment for Its Medical Assisting Program
Genesis Regenerative Appoints Dr. Mark Jacobson as a Medical Director to Lead Regenerative Medicine in The Villages FL
CMG Expands Its Fleet with Versatile 20ft Shipping Containers for Multi-Purpose Use
HearAdvisor Announces New Guide on the Best Hearing Aids and Earplugs of 2025 with Expert Choice Awards
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjögren’s Disease
Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time
Generation Bio Announces CEO Transition
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions